Articles

Information about the TGA's safety monitoring of COVID-19 vaccines

Even if you're familiar with your pet's medicine, the advice is clear: if a product is labelled 'for animal use only', do not take it.

Enforceable Undertaking given by Chemforce Pty Ltd to the Department of Health

Information about the TGA's safety monitoring of COVID-19 vaccines

The granting of this determination means that Pfizer is now eligible to apply to vary its provisional registration for the vaccine for use in individuals 12 years of age or older.

The infringement notice relate to the alleged failure to provide information on a contact person responsible for medicine safety.

Information about the TGA's safety monitoring of COVID-19 vaccines

The TGA is warning consumers about the risks of buying medicinal cannabis products online

The TGA is reminding businesses involved with medicinal cannabis products of their regulatory obligations under the Therapeutic Goods Act 1989

Medicines Safety Update article

Information about the TGA's safety monitoring of COVID-19 vaccines

Global Therapeutics Pty Ltd has paid penalties of $119,880 in response to nine infringement notices

The TGA have made some changes to the SAS & AP Authorised Prescriber Online System.

Important safety information on Aspen Medical respirators, including labelling issues, proper use, and limitations identified during a TGA post‑market review.

Information about the TGA's safety monitoring of COVID-19 vaccines

Information about the TGA's safety monitoring of COVID-19 vaccines

The granting of a provisional determination means that the TGA has made a decision that GSK is now eligible to apply for provisional registration for the treatment in the Australian Register of Therapeutic Goods.

Updated safety advisory - rare and unusual blood clotting syndrome (thrombosis with thrombocytopenia)

TGA has recently approved wider storage and transportation conditions for the Pfizer COVID-19 vaccine in Australia

Updated storage conditions for the Pfizer COVID-19 vaccine

Information about the TGA's safety monitoring of COVID-19 vaccines

The Scheduling Delegate has decided to seek further advice in relation to psilocybin and MDMA

The TGA is investigating the advertising of stem cell therapies to ensure that content in the public domain complies with the Australian rules for advertising therapeutic goods.

Some rare cases of thrombosis associated with thrombocytopenia have been reported overseas following the administration of COVID-19 Vaccine AstraZeneca.

Australia’s vaccine safety and regulatory process is world class and people can be confident that vaccines approved for use are safe and effective.